Prospective Study to Assess Usage, Adherence, Effectiveness of Cabotegravir LA for Pre-Exposure Prophylaxis in the United States in the OPERA Cohort (219844)

17/05/2024
15/07/2026
EU PAS number:
EUPAS1000000165
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ApretudeUpdateOutcomes_OPERA_Final_Protocol_Anonymised.pdf

English (768.61 KB - PDF) View document
Updated protocol

Protocol Amendment 3-Anonymised 22 Jun 2026.pdf

First published: 23/06/2026
English (1.32 MB - PDF) View document
Study results
Study report
Other information